首页> 外国专利> COMPOSITION FOR CAUSING DRUG TOXICITY CAUSED BY CYTOCHROME P450 3A4(CYP3A4)

COMPOSITION FOR CAUSING DRUG TOXICITY CAUSED BY CYTOCHROME P450 3A4(CYP3A4)

机译:造成细胞色素P450 3A4(CYP3A4)引起的药物毒性的成分

摘要

PURPOSE: A composition containing BI-1 protein is provided to enhance activity of cytochrome p450 3A4(CYP3A4) and reduce drug toxicity.;CONSTITUTION: A pharmaceutical composition for reducing drug toxicity caused by activity reduction of cytochrome p450 3A4(CYP3A4) contains BI-1 protein as an active ingredient. The drug which causes toxicity by cytochrome p450 3A4(CYP3A4) activity reduction is clarithromycin, erythromycin, quinidine, alprazolam, and diazepam. A pharmaceutical composition for preventing and treating disorder caused by drug toxicity by cytochrome p450 3A4(CYP3A4) contains BI-1 protein as an active ingredient.;COPYRIGHT KIPO 2010
机译:目的:提供一种含有BI-1蛋白的组合物,以增强细胞色素p450 3A4(CYP3A4)的活性并降低药物毒性。 1种蛋白质为有效成分。通过细胞色素p450 3A4(CYP3A4)活性降低而引起毒性的药物是克拉霉素,红霉素,奎尼丁,阿普唑仑和地西epa。用于预防和治疗由细胞色素p450 3A4(CYP3A4)引起的药物毒性引起的疾病的药物组合物,以BI-1蛋白为有效成分。; COPYRIGHT KIPO 2010

著录项

  • 公开/公告号KR20100017998A

    专利类型

  • 公开/公告日2010-02-16

    原文格式PDF

  • 申请/专利权人 KIM HYUNG RYONG;

    申请/专利号KR20100002116

  • 发明设计人 KIM HYUNG RYONG;CHAE HAN JUNG;

    申请日2010-01-11

  • 分类号A61K38/16;A61P31/00;

  • 国家 KR

  • 入库时间 2022-08-21 18:33:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号